Cargando…

Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer

BACKGROUND: To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. METHODS: Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF t...

Descripción completa

Detalles Bibliográficos
Autores principales: Serre, Antoine, Idri, Katia, Fenoglietto, Pascal, Ailleres, Norbert, Santoro, Lore, Lemanski, Claire, Garrel, Renaud, Makeieff, Marc, Allaw, Ali, Dubois, Jean-Bernard, Azria, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072954/
https://www.ncbi.nlm.nih.gov/pubmed/17877793
http://dx.doi.org/10.1186/1748-717X-2-35
_version_ 1782137809998446592
author Serre, Antoine
Idri, Katia
Fenoglietto, Pascal
Ailleres, Norbert
Santoro, Lore
Lemanski, Claire
Garrel, Renaud
Makeieff, Marc
Allaw, Ali
Dubois, Jean-Bernard
Azria, David
author_facet Serre, Antoine
Idri, Katia
Fenoglietto, Pascal
Ailleres, Norbert
Santoro, Lore
Lemanski, Claire
Garrel, Renaud
Makeieff, Marc
Allaw, Ali
Dubois, Jean-Bernard
Azria, David
author_sort Serre, Antoine
collection PubMed
description BACKGROUND: To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. METHODS: Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF treatment. The maximum point doses (D max) obtained for the different optic pathway structures (OPS) should differ no more than 3% from those achieved with the NCF IMRT plan. The distribution of the dose in the target volume and in the critical structures was compared between the two techniques, as well as the Conformity (CI) and the Homogeneity Indexes (HI) in the target volume. RESULTS: We noted no difference between the two techniques in the OPS for the D1, D2, and D5%, in the inner ear and controlateral lens for the average Dmax, in the temporo-mandibular joints for the average mean dose, in the cord and brainstem for the average D1%. The dose-volume histograms were slightly better with the NCF treatment plan for the planning target volume (PTV) with a marginally better HI but no impact on CI. We found a great improvement in the PTV coverage with the CF treatment plan for two patients with T4 tumors. CONCLUSION: IMRT is one of the treatment options for ethmoid cancer. The PTV coverage is optimal without compromising the protection of the OPS. The impact of non coplanar versus coplanar set up is very slight.
format Text
id pubmed-2072954
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20729542007-11-10 Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer Serre, Antoine Idri, Katia Fenoglietto, Pascal Ailleres, Norbert Santoro, Lore Lemanski, Claire Garrel, Renaud Makeieff, Marc Allaw, Ali Dubois, Jean-Bernard Azria, David Radiat Oncol Research BACKGROUND: To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. METHODS: Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF treatment. The maximum point doses (D max) obtained for the different optic pathway structures (OPS) should differ no more than 3% from those achieved with the NCF IMRT plan. The distribution of the dose in the target volume and in the critical structures was compared between the two techniques, as well as the Conformity (CI) and the Homogeneity Indexes (HI) in the target volume. RESULTS: We noted no difference between the two techniques in the OPS for the D1, D2, and D5%, in the inner ear and controlateral lens for the average Dmax, in the temporo-mandibular joints for the average mean dose, in the cord and brainstem for the average D1%. The dose-volume histograms were slightly better with the NCF treatment plan for the planning target volume (PTV) with a marginally better HI but no impact on CI. We found a great improvement in the PTV coverage with the CF treatment plan for two patients with T4 tumors. CONCLUSION: IMRT is one of the treatment options for ethmoid cancer. The PTV coverage is optimal without compromising the protection of the OPS. The impact of non coplanar versus coplanar set up is very slight. BioMed Central 2007-09-18 /pmc/articles/PMC2072954/ /pubmed/17877793 http://dx.doi.org/10.1186/1748-717X-2-35 Text en Copyright © 2007 Serre et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Serre, Antoine
Idri, Katia
Fenoglietto, Pascal
Ailleres, Norbert
Santoro, Lore
Lemanski, Claire
Garrel, Renaud
Makeieff, Marc
Allaw, Ali
Dubois, Jean-Bernard
Azria, David
Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
title Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
title_full Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
title_fullStr Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
title_full_unstemmed Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
title_short Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
title_sort dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072954/
https://www.ncbi.nlm.nih.gov/pubmed/17877793
http://dx.doi.org/10.1186/1748-717X-2-35
work_keys_str_mv AT serreantoine dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT idrikatia dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT fenogliettopascal dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT ailleresnorbert dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT santorolore dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT lemanskiclaire dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT garrelrenaud dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT makeieffmarc dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT allawali dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT duboisjeanbernard dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer
AT azriadavid dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer